GlassScriptPhysician profile
Olga Lavryk
NPI 1093179418
$2,112.30
in general payments reported to CMS, 2019-2025
11 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $50.44 · 2022: $180 · 2023: $1,286 · 2024: $128 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,339 · Travel and Lodging: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,339.39 |
| Travel and Lodging | $435.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $644.31 | 2023-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $358.83 | 2022-2023 | Ligasure, Eea |
| Baxter Healthcare | $235.67 | 2023-2024 | Tisseel |
| Abbvie INC. | $148.67 | 2023 | |
| Aroa Biosurgery Incorporated | $142.64 | 2025 | |
| Janssen Biotech, INC. | $140.60 | 2025 | Tremfya |
| Pfizer INC. | $107.13 | 2019 | |
| Ferring Pharmaceuticals INC. | $105.98 | 2023 | Rebyota |
| Olympus Corporation of The Americas | $100.99 | 2023 | Evis Exera Lll Colonovideoscope |
| Ethicon US, LLC | $77.04 | 2025 | Echelon Flex, Proximate, Contour |
| Davol INC. | $50.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Lavryk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.